ALPHA-ADRENOCEPTOR VASCULAR FUNCTION IN CHRONIC KIDNEY DISEASE
慢性肾病中的α-肾上腺素受体血管功能
基本信息
- 批准号:7603842
- 负责人:
- 金额:$ 0.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2007-09-16
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic ReceptorBloodBlood PressureBlood VesselsBlood flowChronic Kidney FailureComputer Retrieval of Information on Scientific Projects DatabaseElectrocardiogramEquilibriumExerciseFundingGrantHigh Blood PressureIndividualInpatientsInstitutionKidney DiseasesLaboratoriesLearningPathogenesisPatientsPharmaceutical PreparationsPhysical ExaminationPreventionPurposeRenal functionResearchResearch PersonnelResourcesScreening procedureSourceStagingStudy SubjectTestingUnited States National Institutes of HealthVascular DiseasesWeekinsightresponse
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The purpose of this study is to learn more about why most patients with early stages of kidney disease have high blood pressure.
We know the body produces natural substances that cause blood vessels to open wider to carry more blood when needed. An example is during exercise. Other natural substances cause blood vessels to get smaller and slow down blood flow when needed. An example is when people are cold. The balance between these substances is important. People with kidney disease and high blood pressure do not have the normal balance of these substances.
This study will include 3 groups of people, people with normal blood pressure, people with high blood pressure and people with kidney disease.
" Subjects will have a screening physical examination, including an ECG and laboratory tests
" Subjects with high blood pressure may not take their regular blood pressure medication for 3 weeks prior to the inpatient GCRC study
" Subjects will be given intra-arterial medications that will cause changes in the blood vessels during the in-patient study.
The study will then compare the responses of the three groups. A GFR test will be done to confirm the renal function of the group with chronic kidney disease.
These studies will provide insight into the mechanisms of the pathogenesis of enhanced ¿1 vasoreactivity in subjects with progressive renal disease. This will lay the groundwork for new strategies in the treatment and prevention of vascular disease among the rapidly growing group of individuals with CKD.'
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
这项研究的目的是更多地了解为什么大多数早期肾病患者患有高血压。
我们知道,身体产生的天然物质会使血管在需要时张开,以输送更多的血液。一个例子是在锻炼过程中。其他天然物质会导致血管变小,并在需要时减缓血液流动。一个例子是当人们感到寒冷时。这些物质之间的平衡很重要。患有肾病和高血压的人没有这些物质的正常平衡。
这项研究将包括3组人,血压正常的人,高血压的人和肾脏疾病的人。
“受试者将进行筛选体检,包括ECG和实验室检查
“高血压受试者在住院GCRC研究前3周内不得服用常规血压药物
“在住院研究期间,受试者将接受动脉内药物治疗,这将导致血管发生变化。
然后,研究将比较三组的反应。将进行GFR检测,以确认慢性肾脏疾病组的肾功能。
这些研究将提供对进展性肾病受试者血管反应性增强的发病机制的深入了解。这将为在迅速增长的CKD患者群体中治疗和预防血管疾病的新策略奠定基础。'
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRYSTAL A. GADEGBEKU其他文献
CRYSTAL A. GADEGBEKU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRYSTAL A. GADEGBEKU', 18)}}的其他基金
RETINOPATHY IN CHRONIC RENAL INSUFFICIENCY (RCRIC)
慢性肾功能不全引起的视网膜病变 (RCRIC)
- 批准号:
7603836 - 财政年份:2007
- 资助金额:
$ 0.43万 - 项目类别:
PILOT STUDY ON THE ROLE OF NITRIC OXIDE IN A1 ADRENERGIC VASOREACTIVITY
一氧化氮在 A1 肾上腺素能血管反应性中的作用的初步研究
- 批准号:
7603800 - 财政年份:2007
- 资助金额:
$ 0.43万 - 项目类别:
PILOT STUDY ON THE ROLE OF NITRIC OXIDE IN A1 ADRENERGIC VASOREACTIVITY
一氧化氮在 A1 肾上腺素能血管反应性中的作用的初步研究
- 批准号:
7376637 - 财政年份:2006
- 资助金额:
$ 0.43万 - 项目类别:
INCREASED ALPHA1-ADRENOCEPTOR-MEDIATED PRESSOR SENSITIVITY & CHRONIC RENAL DIS
增加 ALPHA1-肾上腺素受体介导的压力敏感性
- 批准号:
7376575 - 财政年份:2006
- 资助金额:
$ 0.43万 - 项目类别:
Mechanisms of Hypertension in Chronic Kidney Disease
慢性肾脏病高血压的机制
- 批准号:
7084589 - 财政年份:2005
- 资助金额:
$ 0.43万 - 项目类别:
Mechanisms of Hypertension in Chronic Kidney Disease
慢性肾脏病高血压的机制
- 批准号:
7657265 - 财政年份:2005
- 资助金额:
$ 0.43万 - 项目类别:
Mechanisms of Hypertension in Chronic Kidney Disease
慢性肾脏病高血压的机制
- 批准号:
7258381 - 财政年份:2005
- 资助金额:
$ 0.43万 - 项目类别:
Mechanisms of Hypertension in Chronic Kidney Disease
慢性肾脏病高血压的机制
- 批准号:
7471513 - 财政年份:2005
- 资助金额:
$ 0.43万 - 项目类别:
相似海外基金
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
23K24566 - 财政年份:2024
- 资助金额:
$ 0.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Defining a new mechanism of blood pressure regulation and its role during sepsis
定义血压调节的新机制及其在脓毒症期间的作用
- 批准号:
MR/Y011805/1 - 财政年份:2024
- 资助金额:
$ 0.43万 - 项目类别:
Research Grant
Cuffless models to infer blood pressure from bioimpedance
无袖带模型可根据生物阻抗推断血压
- 批准号:
2319920 - 财政年份:2023
- 资助金额:
$ 0.43万 - 项目类别:
Standard Grant
Blood pressure trajectory of inpatient rehabilitation stroke patients from the Determining Optimal Post-Stroke Exercise (DOSE) trial over the first 12-months post-stroke
通过确定最佳中风后运动 (DOSE) 试验得出的中风住院康复患者在中风后 12 个月内的血压轨迹
- 批准号:
493123 - 财政年份:2023
- 资助金额:
$ 0.43万 - 项目类别:
AirPressureNYC: Reducing AIR pollution to lower blood PRESSURE among New York City public housing residents
AirPressureNYC:减少空气污染以降低纽约市公共住房居民的血压
- 批准号:
10638946 - 财政年份:2023
- 资助金额:
$ 0.43万 - 项目类别:
The mechanism of non-dipper blood pressure induced by intermittent hypoxia during sleep
睡眠间歇性缺氧引起非杓型血压的机制
- 批准号:
23K06336 - 财政年份:2023
- 资助金额:
$ 0.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine Learning Enabled Non-contact Sensing Platform for Blood Pressure and Glucose Prediction
用于血压和血糖预测的机器学习非接触式传感平台
- 批准号:
23K11341 - 财政年份:2023
- 资助金额:
$ 0.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
I-Corps: Blood Pressure Monitoring by a Miniaturized Cuffless Sensor
I-Corps:通过小型无袖带传感器进行血压监测
- 批准号:
2332674 - 财政年份:2023
- 资助金额:
$ 0.43万 - 项目类别:
Standard Grant
Blood pressure imaging by contrast enhanced active Doppler ultrasound
通过对比增强主动多普勒超声进行血压成像
- 批准号:
23K18557 - 财政年份:2023
- 资助金额:
$ 0.43万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
- 批准号:
10555126 - 财政年份:2023
- 资助金额:
$ 0.43万 - 项目类别: